Highlighting the day’s most compelling companies and events: Notable movers post-closing bell include Micron, which saw a slight increase subsequent to its initial post-earnings jump. As the evening session opened, US equity futures emerged as the key focus. The leading averages ended on a down note, marking an end to a series of consecutive record-setting closes, closely followed by investors.
Micron’s fourth-quarter earnings per share (EPS) were reported at $3.03, surpassing the predicted figure of $2.86. The company documented the fourth quarter’s revenue to be $11.32 billion, more than the projected $11.16 billion. The end of an extraordinary fiscal year for Micron echoed in their record-breaking returns.
Investment banking giant JPMorgan has expressed bullish sentiments towards Didi Global, initiating respective coverage. A constructive ‘Overweight’ rating has been ascertained along with a ten dollar price for the Chinese ride-hailing conglomerate. These aspects substantiate JPMorgan’s asserted prediction and valuation for Didi Global.
With an anticipated first quarter EPS at around $3.75, plus or minus 15c, Micron’s expectations outpace the consensus of $3.04. In terms of revenue, $12.5 billion is expected, within a range of plus or minus $300 million, again beating the consensus of $11.83 billion. This projection includes a promising Q1 gross margin of 51.5%, flexible by 1%.
From earnings calls to government events, analyst meets to corporate roadshows, there are a host of noteworthy events on the horizon. An example is the MBA Mortgage Applications Composite Index W/W for the week of September 19, 2025. Stakeholders have a keen interest in key indicators like this, which provide valuable insight into the state of the economy.
In addition to the Composite Index, the MBA Mortgage Applications Purchase Index W/W and the Refinance Index W/W, both for the week of September 19, 2025, also feature in the day’s government agenda. These indices form an integral part of economic data analysis, helping to provide a clearer vision of market trends.
The day also includes events organized by firms such as Culp Inc. and Worthington Steel Inc., as these corporate-sponsored meetings offer exclusive access to company insights and the opportunity for meaningful engagement with key stakeholders.
On the docket furthermore, are critical conversations set to take place involving companies such as New Home Sales and Edible Garden AG Inc. The annual sales rate for August 2025 and sponsored meetings for Edible Garden AG Inc. presents an intriguing forward-looking snapshot of the evolving business landscape.
The event driven day also embraces firm initiated meetings by Cannabist Company Holdings Inc. Such gatherings are significant, presenting an opportunity for enterprises to interact directly with their stakeholders and ensure transparent communication.
Looking at the week ahead, there are several IPOs and secondary offerings coming up. Eupraxia Pharmaceuticals is set to release a spot secondary, under the ticker EPRXXEPRX. Often, events like this can serve as a potential investment opportunity for investors scouting the biotech space.
The anticipated schedule however indicates no deals for the following days of the current week. As is the case often in the financial world, there can be unexpected lulls or influx of deals. Such absences present a time to reflect upon market conditions and strategize for impending market moves.
The subsequent week stock schedule also shows an absence of notable deals thus far. Solid predictions about deal flows can be challenging, given the highly dynamic nature of the financial marketplace. There’s always the possibility of surprise events, which can significantly influence the overall investing climate.
However, the roadmap hints at an imminent secondary offering by MBX Biosciences, represented by the ticker MBXXMBX. Trackers of biosciences companies may find such market events relevant because they provide significant insights into business performance and strategies.
In conclusion, while some periods can be teeming with major deals and headline-grabbing IPOs or secondary offerings, others may not be as dynamic. Still, periods devoid of deal news offer an opportune moment for investors to take stock of current market conditions, deploy strategy, and prepare for future opportunities.
The post Micron Outperforms Estimates, Posts Remarkable Q4 Earnings appeared first on Real News Now.
About Author
